Kilroy Conor sold Aura Biosciences ($AURA) shares on the open market twice in the last year, totaling just over $100,000, with the most recent sale on February 17, 2026. These sales rank 9,574th among 11,678 individual insiders, far below the average of $8.6 million per seller and 6.4 transactions. Conor made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Aura Biosciences, Inc. | $AURA | Kilroy Conor | See Remarks | A | Stock Option (Right to Buy) | 112661 | $0.00 | 112,661.0000 | 65,936,672 | 9999.99% | 0.17% |
| March 2, 2026 | Aura Biosciences, Inc. | $AURA | Kilroy Conor | See Remarks | A | Common Stock | 62339 | $0.00 | 229,573.0000 | 65,936,672 | 37.28% | 0.09% |
| Feb. 17, 2026 | Aura Biosciences, Inc. | $AURA | Kilroy Conor | See Remarks | S | Common Stock | 12079 | $5.05 | 167,234.0000 | 65,936,672 | 6.74% | 0.02% |
| April 16, 2025 | Aura Biosciences, Inc. | $AURA | Kilroy Conor | See Remarks | S | Common Stock | 7162 | $5.49 | 179,313.0000 | 49,650,480 | 3.84% | 0.01% |
| Feb. 3, 2025 | Aura Biosciences, Inc. | $AURA | Kilroy Conor | See Remarks | A | Stock Option (Right to Buy) | 59525 | $0.00 | 59,525.0000 | 49,650,480 | 9999.99% | 0.12% |
| Feb. 3, 2025 | Aura Biosciences, Inc. | $AURA | Kilroy Conor | See Remarks | A | Common Stock | 90475 | $0.00 | 186,475.0000 | 49,650,480 | 94.24% | 0.18% |
| April 2, 2024 | Aura Biosciences, Inc. | $AURA | Kilroy Conor | General Counsel and Secretary | A | Stock Option (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 39,620,036 | 9999.99% | 0.36% |
| April 2, 2024 | Aura Biosciences, Inc. | $AURA | Kilroy Conor | General Counsel and Secretary | A | Common Stock | 96000 | $0.00 | 96,000.0000 | 39,620,036 | 9999.99% | 0.24% |